India News | Reported by Sukirti Dwivedi, Edited by Divyanshu Dutta Roy | Friday January 22, 2021
Covaxin, India's first indigenous vaccine against COVID-19, showed enhanced immune response without any serious side effects in the Phase 1 trials, according to the results published in well-respected Lancet Infectious Disease journal on Friday.
www.ndtv.com